Author

P. Gandhi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Majumder· 2 shared S. Yadav· 2 shared A. Aggarwal· 1 shared A. Chande· 1 shared A. Kumar· 1 shared A. T. Takaoka· 1 shared B. S. Rawat· 1 shared D. Khetan· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. Majumder

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Lithography-less, frugal and long-term diffusion-based static gradient generating microfluidic device for high-throughput drug testing

K. J. Bachal, S. Yadav, P. Gandhi, A. Majumder

This paper presents a microfluidic device for drug testing that generates stable concentration gradients without requiring complex fabrication or accessories, validated with drug efficacy tests on cancer cells.

bioRxiv · Aug 30, 2022 · PreprintCell Biology

Scalable large-area mesh-structured microfluidic gradient generator for drug testing applications

S. Yadav, P. Tawade, K. Bachal, M. Rakshe, Y. Pundlik, P. Gandhi, A. Majumder

This paper develops a cost-effective, scalable microfluidic gradient generator for drug testing, validated with curcumin on HeLa cells, showing comparable IC50 values to conventional methods.

bioRxiv · Jul 14, 2022Bioengineering

Integrated role of microRNA-30e-5p through targeting negative regulators of innate immune pathways during HBV infection and SLE

R. Mishra, S. Bhattacharya, B. S. Rawat, A. Kumar, A. Kumar, K. Niraj, A. Chande, P. Gandhi, D. Khetan, A. Aggarwal, S. Sato, P. Tailor, A. T. Takaoka, H. Kumar

This study identifies miR-30e as a master regulator of innate immune responses during HBV infection and SLE, showing its role in modulating immune pathways and therapeutic potential.

bioRxiv · Feb 29, 2020Immunology